Genomic Vision Announces the Issuance of the 2nd Tranche of Convertible Notes

By using the delegation granted by the extraordinary shareholders meeting, Genomic Vision’s Executive Board opted, on March 1st, 2021, for the issuance of 1,200 OCABSA for a total amount of 1.2 million euros for the benefit of Winance or any affiliate entity.